James Hassard
Corporate Officer/Principal en CRINETICS PHARMACEUTICALS, INC. .
Fortuna: 1 M $ al 30/04/2024
Perfil
James Hassard is currently the Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. He previously held the position of Chief Commercial Officer at Arrowhead Pharmaceuticals, Inc. from 2020 to 2021.
Prior to that, he was the Vice President-Marketing at Medivation LLC (California) and the General Manager at Amgen BIO Farmaceutica Ltda.
From 2016 to 2020, he served as the Senior Vice President-Marketing & Market Access at Coherus BioSciences, Inc. Mr. Hassard holds an MBA from Nova Southeastern University, Inc. and an undergraduate degree from the University of Toronto.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
15/04/2024 | 29 259 ( 0.04% ) | 1 M $ | 30/04/2024 |
Cargos activos de James Hassard
Empresas | Cargo | Inicio |
---|---|---|
CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2022 |
Antiguos cargos conocidos de James Hassard.
Empresas | Cargo | Fin |
---|---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 23/08/2021 |
COHERUS BIOSCIENCES, INC. | Ventas & Marketing | 01/01/2020 |
Amgen BIO Farmaceutica Ltda | Corporate Officer/Principal | - |
MEDIVATION INC | Ventas & Marketing | - |
Formación de James Hassard.
Nova Southeastern University, Inc. | Masters Business Admin |
University of Toronto | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
COHERUS BIOSCIENCES, INC. | Health Technology |
CRINETICS PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Amgen BIO Farmaceutica Ltda |
- Bolsa de valores
- Insiders
- James Hassard